Prevalence of the consumption of anticholinergic drugs in HIV patients
Objective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the ACB and ARS scales; and to determine if these patients use any type of benzodiazepine. Method: A descriptive observational study of 256 HIV patients 50 years o...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-01-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10842.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846146040105795584 |
|---|---|
| author | Ricardo Zafra-Morales Yared González-Pérez María José Nebot-Villacampa Jara Gallardo-Anciano Raquel Marín-Gorricho Andrea Casajús-Navasal |
| author_facet | Ricardo Zafra-Morales Yared González-Pérez María José Nebot-Villacampa Jara Gallardo-Anciano Raquel Marín-Gorricho Andrea Casajús-Navasal |
| author_sort | Ricardo Zafra-Morales |
| collection | DOAJ |
| description | Objective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the ACB and ARS scales; and to determine if these patients use any type of benzodiazepine.
Method: A descriptive observational study of 256 HIV patients 50 years or older.
Results: 73.1% were men. Mean age was 56 ± 5.9 years. 55.9% of the patients were coinfected with HCV. Excluding HIV drugs, mean drug consumption was 2.9 ± 2.9 drugs per patient. The ACB and ARS scales showed that 26.2% and 17.2% of the patients took an anticholinergic agent, and that 43.3% and 36.4% presented high anticholinergic risk, respectively. 30.5% of patients consumed benzodiazepines.
Conclusions: The percentage of HIV patients aged 50 years or older who were taking anticholinergic agents was statistically significantly higher on the ACB scale than on the ARS scale. No studies are available on the HIV population with which to compare our results, but there is evidence that this group of drugs can affect older adults. |
| format | Article |
| id | doaj-art-91807ddc55e546f38a1e96b54b1c49c6 |
| institution | Kabale University |
| issn | 1130-6343 2171-8695 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Farmacia Hospitalaria |
| spelling | doaj-art-91807ddc55e546f38a1e96b54b1c49c62024-12-02T04:56:15ZengElsevierFarmacia Hospitalaria1130-63432171-86952018-01-0142011410.7399/fh.10842Prevalence of the consumption of anticholinergic drugs in HIV patientsRicardo Zafra-Morales0Yared González-Pérez1María José Nebot-Villacampa2Jara Gallardo-Anciano3Raquel Marín-Gorricho4Andrea Casajús-Navasal5Servicio de Farmacia, Hospital San Pedro, LogroñoServicio de Farmacia, Hospital San Pedro, LogroñoServicio de Farmacia, Hospital San Pedro, LogroñoServicio de Farmacia, Hospital San Pedro, LogroñoServicio de Farmacia, Hospital San Pedro, LogroñoServicio de Farmacia, Hospital San Pedro, LogroñoObjective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to determine anticholinergic risk using the ACB and ARS scales; and to determine if these patients use any type of benzodiazepine. Method: A descriptive observational study of 256 HIV patients 50 years or older. Results: 73.1% were men. Mean age was 56 ± 5.9 years. 55.9% of the patients were coinfected with HCV. Excluding HIV drugs, mean drug consumption was 2.9 ± 2.9 drugs per patient. The ACB and ARS scales showed that 26.2% and 17.2% of the patients took an anticholinergic agent, and that 43.3% and 36.4% presented high anticholinergic risk, respectively. 30.5% of patients consumed benzodiazepines. Conclusions: The percentage of HIV patients aged 50 years or older who were taking anticholinergic agents was statistically significantly higher on the ACB scale than on the ARS scale. No studies are available on the HIV population with which to compare our results, but there is evidence that this group of drugs can affect older adults.http://www.aulamedica.es/fh/pdf/10842.pdfHIVElderlyAnticholinergic Cognitive Burden Scale (ACB)Anticholinergic Risk Scale (ARS);Benzodiazepine. |
| spellingShingle | Ricardo Zafra-Morales Yared González-Pérez María José Nebot-Villacampa Jara Gallardo-Anciano Raquel Marín-Gorricho Andrea Casajús-Navasal Prevalence of the consumption of anticholinergic drugs in HIV patients Farmacia Hospitalaria HIV Elderly Anticholinergic Cognitive Burden Scale (ACB) Anticholinergic Risk Scale (ARS); Benzodiazepine. |
| title | Prevalence of the consumption of anticholinergic drugs in HIV patients |
| title_full | Prevalence of the consumption of anticholinergic drugs in HIV patients |
| title_fullStr | Prevalence of the consumption of anticholinergic drugs in HIV patients |
| title_full_unstemmed | Prevalence of the consumption of anticholinergic drugs in HIV patients |
| title_short | Prevalence of the consumption of anticholinergic drugs in HIV patients |
| title_sort | prevalence of the consumption of anticholinergic drugs in hiv patients |
| topic | HIV Elderly Anticholinergic Cognitive Burden Scale (ACB) Anticholinergic Risk Scale (ARS); Benzodiazepine. |
| url | http://www.aulamedica.es/fh/pdf/10842.pdf |
| work_keys_str_mv | AT ricardozaframorales prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients AT yaredgonzalezperez prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients AT mariajosenebotvillacampa prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients AT jaragallardoanciano prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients AT raquelmaringorricho prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients AT andreacasajusnavasal prevalenceoftheconsumptionofanticholinergicdrugsinhivpatients |